Cargando…
Comparison of msp genotyping and a 24 SNP molecular assay for differentiating Plasmodium falciparum recrudescence from reinfection
BACKGROUND: Current World Health Organization guidelines for conducting anti-malarial drug efficacy clinical trials recommend genotyping Plasmodium falciparum genes msp1 and msp2 to distinguish recrudescence from reinfection. A more recently developed potential alternative to this method is a molecu...
Autores principales: | Fulakeza, Joseph, McNitt, Sarah, Vareta, Jimmy, Saidi, Alex, Mvula, Godfrey, Taylor, Terrie, Mathanga, Don P., Small, Dylan S., Skarbinski, Jacek, Gutman, Julie R., Seydel, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423793/ https://www.ncbi.nlm.nih.gov/pubmed/30885193 http://dx.doi.org/10.1186/s12936-019-2695-0 |
Ejemplares similares
-
Comparison of Two Genotyping Methods for Distinguishing Recrudescence from Reinfection in Antimalarial Drug Efficacy/Effectiveness Trials
por: Fulakeza, Joseph R. M., et al.
Publicado: (2018) -
Subtle changes in Plasmodium falciparum infection complexity following enhanced intervention in Malawi
por: Sisya, Tamika J., et al.
Publicado: (2015) -
A case of Plasmodium malariae recurrence: recrudescence or reinfection?
por: Grande, Romualdo, et al.
Publicado: (2019) -
Distinction of Plasmodium falciparum recrudescence and re-infection by MSP2 genotyping: A caution about unstandardized classification criteria
por: Rouse, Petrica, et al.
Publicado: (2008) -
Repeat or persistent Lyme disease: persistence, recrudescence or reinfection with Borrelia Burgdorferi?
por: Shapiro, Eugene D.
Publicado: (2015)